ABSTRACT
Normal female fertility relies on proper development of the oocyte. This growth culminates just prior to ovulation, when oocyte maturation occurs. Oocyte maturation refers to a release of meiotic arrest that allows oocytes to advance from prophase I to metaphase II of meiosis. This precisely regulated meiotic progression is essential for normal ovulation and subsequent fertilization, and involves changes in the delicate balance between factors promoting meiotic arrest and others that are stimulating maturation. Most of the inhibitory mechanisms appear to involve the upregulation of intracellular cyclic adenosine monophosphate levels. These processes may include direct transport of the nucleotide into oocytes via gap junctions, G protein-mediated stimulation of adenylyl cyclase, and inhibition of intracellular phosphodiesterases. In contrast, potential factors that play roles in triggering oocyte maturation include gonadotropins (e.g., follicle-stimulating factor and luteinizing hormone), growth factors (e.g., amphiregulin and epiregulin), sterols (e.g., follicular fluid-derived meiosis-activating sterol), and steroids (e.g., testosterone progesterone, and estradiol). Delineating the complex interactions between these positive and negative components is critical for determining the role that oocyte maturation plays in regulating follicle development and ovulation, and may lead to novel methods that can be used to modulate these processes in women with both normal and aberrant fertility.
KEYWORDS
Oocyte - ovary - maturation - steroids - nongenomic
REFERENCES
1
Albertini D F, Carabatsos M J.
Comparative aspects of meiotic cell cycle control in mammals.
J Mol Med.
1998;
76
795-799
2
Albertini D F, Combelles C M, Benecchi E, Carabatsos M J.
Cellular basis for paracrine regulation of ovarian follicle development.
Reproduction.
2001;
121
647-653
3
diZerega G S, Hodgen G D.
Folliculogenesis in the primate ovarian cycle.
Endocr Rev.
1981;
2
27-49
4 Griffin J E, Ojeda S R. Textbook of Endocrine Physiology, 4th ed. New York; Oxford University Press 2000
5
Mandl A M, Zuckerman S.
The relation of age to numbers of oocytes.
J Endocrinol.
1951;
7
190-193
6
Johnson J, Canning J, Kaneko T, Pru J K, Tilly J L.
Germline stem cells and follicular renewal in the postnatal mammalian ovary.
Nature.
2004;
428
145-150
7 Hausen P. The Early Development of Xenopus laevis: An Atlas of the Histology New York; Springer-Verlag 1991
8
Keem K, Smith L D, Wallace R A, Wolf D.
Growth rate of oocytes in laboratory maintained Xenopus laevis
.
Gamete Res.
1979;
2
125-135
9
Smith C L.
Reproduction in female Amphibia.
Mem Soc Endocrinol.
1955;
4
39-56
10
Edwards R G.
Maturation in vitro of human ovarian oocytes.
Lancet.
1965;
2
926-929
11
Edwards R G.
Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes.
Nature.
1965;
208
349-351
12
Maller J L, Krebs E G.
Regulation of oocyte maturation.
Curr Top Cell Regul.
1980;
16
271-311
13
Smith L D, Ecker R E.
The interaction of steroids with Rana pipiens oocytes in the induction of maturation.
Dev Biol.
1971;
25
232-247
14
Conti M, Andersen C B, Richard F et al..
Role of cyclic nucleotide signaling in oocyte maturation.
Mol Cell Endocrinol.
2002;
187
153-159
15
Freissmuth M, Casey P J, Gilman A G.
G proteins control diverse pathways of transmembrane signaling.
FASEB J.
1989;
3
2125-2131
16
Mehats C, Andersen C B, Filopanti M, Jin S L, Conti M.
Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling.
Trends Endocrinol Metab.
2002;
13
29-35
17
Conti M, Andersen C B, Richard F J, Shitsukawa K, Tsafriri A.
Role of cyclic nucleotide phosphodiesterases in resumption of meiosis.
Mol Cell Endocrinol.
1998;
145
9-14
18
Mehlmann L M, Jones T L, Jaffe L A.
Meiotic arrest in the mouse follicle maintained by a Gs protein in the oocyte.
Science.
2002;
297
1343-1345
19
Wiersma A, Hirsch B, Tsafriri A et al..
Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents.
J Clin Invest.
1998;
102
532-537
20
Morrill G A, Schatz F, Kostellow A B, Poupko J M.
Changes in cyclic AMP levels in the amphibian ovarian follicle following progesterone induction of meiotic maturation. Effect of phosphodiesterase inhibitors and exogenous calcium on germinal vesicle breakdown.
Differentiation.
1977;
8
97-104
21
Sadler S E, Maller J L.
Progesterone inhibits adenylate cyclase in Xenopus oocytes. Action on the guanine nucleotide regulatory protein.
J Biol Chem.
1981;
256
6368-6373
22
Sadler S E, Maller J L.
Inhibition of Xenopus oocyte adenylate cyclase by progesterone: a novel mechanism of action.
Adv Cyclic Nucleotide Protein Phosphorylation Res.
1985;
19
179-194
23
Lutz L B, Cole L M, Gupta M K, Kwist K W, Auchus R J, Hammes S R.
Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation.
Proc Natl Acad Sci USA.
2001;
98
13728-13733
24
Sheng Y, Tiberi M, Booth R A, Ma C, Liu X J.
Regulation of Xenopus oocyte meiosis arrest by G protein betagamma subunits.
Curr Biol.
2001;
11
405-416
25
Gallo C J, Hand A R, Jones T L, Jaffe L A.
Stimulation of Xenopus oocyte maturation by inhibition of the G-protein alpha S subunit, a component of the plasma membrane and yolk platelet membranes.
J Cell Biol.
1995;
130
275-284
26
Hammes S R.
The further redefining of steroid-mediated signaling.
Proc Natl Acad Sci USA.
2003;
100
2168-2170
27a
Hammes S R.
Steroids and oocyte maturation-a new look at an old story.
Mol Endocrinol.
2004;
18
769-775
27b
Mehlmann L M, Saeki Y, Tanaka S et al..
The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes.
Science.
2004;
306
1947-1950
28
Gelerstein S, Shapira H, Dascal N, Yekuel R, Oron Y.
Is a decrease in cyclic AMP a necessary and sufficient signal for maturation of amphibian oocytes?.
Dev Biol.
1988;
127
25-32
29
Faure S, Morin N, Doree M.
Inactivation of protein kinase A is not required for c-mos translation during meiotic maturation of Xenopus oocytes.
Oncogene.
1998;
17
1215-1221
30
Eppig J J, Downs S M.
Gonadotropin-induced murine oocyte maturation in vivo is not associated with decreased cyclic adenosine monophosphate in the oocyte-cumulus cell complex.
Gamete Res.
1988;
20
125-131
31
Shim C, Lee D K, Lee C C, Cho W K, Kim K.
Inhibitory effect of purines in meiotic maturation of denuded mouse oocytes.
Mol Reprod Dev.
1992;
31
280-286
32
Downs S M, Daniel S A, Bornslaeger E A, Hoppe P C, Eppig J J.
Maintenance of meiotic arrest in mouse oocytes by purines: modulation of cAMP levels and cAMP phosphodiesterase activity.
Gamete Res.
1989;
23
323-334
33
Eppig J J, Downs S M.
The effect of hypoxanthine on mouse oocyte growth and development in vitro: maintenance of meiotic arrest and gonadotropin-induced oocyte maturation.
Dev Biol.
1987;
119
313-321
34
Ackert C L, Gittens J E, O’Brien M J, Eppig J J, Kidder G M.
Intercellular communication via connexin43 gap junctions is required for ovarian folliculogenesis in the mouse.
Dev Biol.
2001;
233
258-270
35
Browne C L, Wiley H S, Dumont J N.
Oocyte-follicle cell gap junctions in Xenopus laevis and the effects of gonadotropin on their permeability.
Science.
1979;
203
182-183
36
Herlands R L, Schultz R M.
Regulation of mouse oocyte growth: probable nutritional role for intercellular communication between follicle cells and oocytes in oocyte growth.
J Exp Zool.
1984;
229
317-325
37
Eppig J J.
Further reflections on culture systems for the growth of oocytes in vitro.
Hum Reprod.
1994;
9
974-976
38
Peng X R, Hsueh A J, LaPolt P S, Bjersing L, Ny T.
Localization of luteinizing hormone receptor messenger ribonucleic acid expression in ovarian cell types during follicle development and ovulation.
Endocrinology.
1991;
129
3200-3207
39
Downs S M, Daniel S A, Eppig J J.
Induction of maturation in cumulus cell-enclosed mouse oocytes by follicle-stimulating hormone and epidermal growth factor: evidence for a positive stimulus of somatic cell origin.
J Exp Zool.
1988;
245
86-96
40
Park J Y, Su Y Q, Ariga M, Law E, Jin S L, Conti M.
EGF-like growth factors as mediators of LH action in the ovulatory follicle.
Science.
2004;
303
682-684
41
Kanemitsu M Y, Lau A F.
Epidermal growth factor stimulates the disruption of gap junctional communication and connexin43 phosphorylation independent of 12-0-tetradecanoylphorbol 13-acetate-sensitive protein kinase C: the possible involvement of mitogen-activated protein kinase.
Mol Biol Cell.
1993;
4
837-848
42
Lampe P D, Lau A F.
The effects of connexin phosphorylation on gap junctional communication.
Int J Biochem Cell Biol.
2004;
36
1171-1186
43
Xia G, Byskov A G, Andersen C Y.
Cumulus cells secrete a meiosis-inducing substance by stimulation with forskolin and dibutyric cyclic adenosine monophosphate.
Mol Reprod Dev.
1994;
39
17-24
44
Byskov A G, Yding Andersen C, Hossaini A, Guoliang X.
Cumulus cells of oocyte-cumulus complexes secrete a meiosis-activating substance when stimulated with FSH.
Mol Reprod Dev.
1997;
46
296-305
45
Byskov A G, Andersen C Y, Nordholm L et al..
Chemical structure of sterols that activate oocyte meiosis.
Nature.
1995;
374
559-562
46
Lu Z, Xia G, Byskov A G, Andersen C Y.
Effects of amphotericin B and ketoconazole on mouse oocyte maturation: implications on the role of meiosis-activating sterol.
Mol Cell Endocrinol.
2000;
164
191-196
47
Xie H, Xia G, Byskov A G, Andersen C Y, Bo S, Tao Y.
Roles of gonadotropins and meiosis-activating sterols in meiotic resumption of cultured follicle-enclosed mouse oocytes.
Mol Cell Endocrinol.
2004;
218
155-163
48
Yoshida Y, Yamashita C, Noshiro M, Fukuda M, Aoyama Y.
Sterol 14-demethylase P450 activity expressed in rat gonads: contribution to the formation of mammalian meiosis-activating sterol.
Biochem Biophys Res Commun.
1996;
223
534-538
49
Grondahl C, Breinholt J, Wahl P et al..
Physiology of meiosis-activating sterol: endogenous formation and mode of action.
Hum Reprod.
2003;
18
122-129
50
Gross M D, Gosnell M, Tsarbopoulos A, Hunziker W.
A functional and degenerate pair of EF hands contains the very high affinity calcium-binding site of calbindin-D28K.
J Biol Chem.
1993;
268
20917-20922
51
Tsafriri A, Popliker M, Nahum R, Beyth Y.
Effects of ketoconazole on ovulatory changes in the rat: implications on the role of a meiosis-activating sterol.
Mol Hum Reprod.
1998;
4
483-489
52
Tsafriri A, Cao X, Vaknin K M, Popliker M.
Is meiosis activating sterol (MAS) an obligatory mediator of meiotic resumption in mammals.
Mol Cell Endocrinol.
2002;
187
197-204
53
Downs S M, Ruan B, Schroepfer Jr G J.
Meiosis-activating sterol and the maturation of isolated mouse oocytes.
Biol Reprod.
2001;
64
80-89
54
Yamashita M, Kajiura H, Tanaka T, Onoe S, Nagahama Y.
Molecular mechanisms of the activation of maturation-promoting factor during goldfish oocyte maturation.
Dev Biol.
1995;
168
62-75
55
Faerge I, Terry B, Kalous J et al..
Resumption of meiosis induced by meiosis-activating sterol has a different signal transduction pathway than spontaneous resumption of meiosis in denuded mouse oocytes cultured in vitro.
Biol Reprod.
2001;
65
1751-1758
56
Vaknin K M, Lazar S, Popliker M, Tsafriri A.
Role of meiosis-activating sterols in rat oocyte maturation: effects of specific inhibitors and changes in the expression of lanosterol 14alpha-demethylase during the preovulatory period.
Biol Reprod.
2001;
64
299-309
57
Cavilla J L, Kennedy C R, Baltsen M, Klentzeris L D, Byskov A G, Hartshorne G M.
The effects of meiosis activating sterol on in-vitro maturation and fertilization of human oocytes from stimulated and unstimulated ovaries.
Hum Reprod.
2001;
16
547-555
58
Marin Bivens C L, Grondahl C, Murray A, Blume T, Su Y Q, Eppig J J.
Meiosis-activating sterol promotes the metaphase I to metaphase II transition and preimplantation developmental competence of mouse oocytes maturing in vitro.
Biol Reprod.
2004;
70
1458-1464
59
Smith L D, Ecker R E, Subtelny S.
In vitro induction of physiological maturation in Rana pipiens oocytes removed from their ovarian follicles.
Dev Biol.
1968;
17
627-643
60
Le Goascogne C, Sananes N, Gouezou M, Baulieu E E.
Testosterone-induced meiotic maturation of Xenopus laevis oocytes: evidence for an early effect in the synergistic action of insulin.
Dev Biol.
1985;
109
9-14
61
Lutz L B, Jamnongjit M, Yang W H, Jahani D, Gill A, Hammes S R.
Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands.
Mol Endocrinol.
2003;
17
1106-1116
62
Bayaa M, Booth R A, Sheng Y, Liu X J.
The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechanism.
Proc Natl Acad Sci USA.
2000;
97
12607-12612
63
Tian J, Kim S, Heilig E, Ruderman J V.
Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation.
Proc Natl Acad Sci USA.
2000;
97
14358-14363
64
Yamashita Y, Shimada M, Okazaki T, Maeda T, Terada T.
Production of progesterone from de novo-synthesized cholesterol in cumulus cells and its physiological role during meiotic resumption of porcine oocytes.
Biol Reprod.
2003;
68
1193-1198
65
Sadler S E, Jacobs N D.
Stimulation of Xenopus laevis oocyte maturation by methyl-beta-cyclodextrin.
Biol Reprod.
2004;
70
1685-1692
66
Eppig J J, Freter R R, Ward-Bailey P F, Schultz R M.
Inhibition of oocyte maturation in the mouse: participation of cAMP, steroid hormones, and a putative maturation-inhibitory factor.
Dev Biol.
1983;
100
39-49
67
Rice C, McGaughey R W.
Effect of testosterone and dibutyryl cAMP on the spontaneous maturation of pig oocytes.
J Reprod Fertil.
1981;
62
245-256
68
Smith D M, Tenney D Y.
Effects of steroids on mouse oocyte maturation in vitro.
J Reprod Fertil.
1980;
60
331-338
69
Schultz R M, Montgomery R R, Ward-Bailey P F, Eppig J J.
Regulation of oocyte maturation in the mouse: possible roles of intercellular communication, cAMP, and testosterone.
Dev Biol.
1983;
95
294-304
70
Gill A, Jamnongjit M, Hammes S R.
Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis.
Mol Endocrinol.
2004;
18
97-104
71
Borman S M, Chaffin C L, Schwinof K M, Stouffer R L, Zelinski-Wooten M B.
Progesterone promotes oocyte maturation, but not ovulation, in nonhuman primate follicles without a gonadotropin surge.
Biol Reprod.
2004;
71
366-373
72
Ehrmann D A, Sturis J, Byrne M M, Karrison T, Rosenfield R L, Polonsky K S.
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
J Clin Invest.
1995;
96
520-527
73
Dunaif A, Segal K R, Futterweit W, Dobrjansky A.
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
Diabetes.
1989;
38
1165-1174
74
Dunaif A.
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
Endocr Rev.
1997;
18
774-800
75
Pache T D, Chadha S, Gooren L J et al..
Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?.
Histopathology.
1991;
19
445-452
76
Speiser P W.
Congenital adrenal hyperplasia: transition from childhood to adulthood.
J Endocrinol Invest.
2001;
24
681-691
77
Ito Y, Fisher C R, Conte F A, Grumbach M M, Simpson E R.
Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries.
Proc Natl Acad Sci USA.
1993;
90
11673-11677
78
Gambineri A, Pelusi C, Genghini S et al..
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
Clin Endocrinol (Oxf).
2004;
60
241-249
79
Rittmaster R S.
Antiandrogen treatment of polycystic ovary syndrome.
Endocrinol Metab Clin North Am.
1999;
28
409-421
80
Eagleson C A, Gingrich M B, Pastor C L et al..
Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
J Clin Endocrinol Metab.
2000;
85
4047-4052
81
De Leo V, Lanzetta D, D’Antona D, la Marca A, Morgante G.
Hormonal effects of flutamide in young women with polycystic ovary syndrome.
J Clin Endocrinol Metab.
1998;
83
99-102
82
Koivunen R M, Morin-Papunen L C, Ruokonen A, Tapanainen J S, Martikainen H K.
Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
Hum Reprod.
2001;
16
2546-2551
83
Balen A.
Ovulation induction for polycystic ovary syndrome.
Hum Fertil (Camb).
2000;
3
106-111
84
Coffler M S, Patel K, Dahan M H et al..
Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome.
J Clin Endocrinol Metab.
2003;
88
1742-1747
Stephen R HammesM.D. Ph.D.
Department of Internal Medicine, Division of Endocrinology and Metabolism, Department of Pharmacology
University of Texas Southwestern Medical Center at Dallas
5323 Harry Hines Blvd., Dallas, TX 75390-8857
eMail: stephen.hammes@utsouthwestern.edu